CoreCap Advisors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CoreCap Advisors's BLUE Position: Q2 2025 in Review
CoreCap Advisors sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 90 shares — an estimated $439 sold.
CoreCap Advisors first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $439 in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- CoreCap Advisors reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- CoreCap Advisors sold 90 bluebird bio shares in Q2 2025, an estimated $439.
- CoreCap Advisors first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
- CoreCap Advisors's bluebird bio position peaked at $439 in Q1 2025.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.